Business Description
Founded in 2013 and headquartered in Wuxi, China, WuXi XDC Cayman Inc. is a subsidiary of WuXi Biologics that provides contract research, development, and manufacturing services to clients across China, North America, Europe, and beyond. The company specializes in antibody-drug conjugates and related biological compounds, supporting customers from early discovery through to finished drug products. It also develops and markets its own cancer treatments and maintains strategic partnerships with Earendil Labs and Akari Therapeutics.
